StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH stock opened at $0.05 on Monday. The company’s 50-day moving average price is $0.05 and its 200-day moving average price is $0.06. The stock has a market cap of $661,805.30, a price-to-earnings ratio of -0.06 and a beta of 0.67. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high of $11.15.
Bellerophon Therapeutics Company Profile
See Also
- Five stocks we like better than Bellerophon Therapeutics
- Dividend Payout Ratio Calculator
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to invest in blue chip stocks
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.